Press Releases

Syner-G Biopharma Group Appoints Ron Kraus as CEO

RESEARCH TRIANGLE PARK, NC: 13 June 2022 Syner-G BioPharma Group (“Syner-G”), a leading provider of consulting services to pharmaceutical and biotechnology clients, today announced that Ron Kraus has joined the company as Chief Executive Officer (CEO). Mr. Kraus has...

read more

IMPACT Celebrates Award from 200th Client

Research Triangle Park, NC—November 15, 2021 – In a virtual gathering, Impact Pharmaceutical Services, Inc. (IMPACT) (now Syner-G BioPharma Group) team members opened boxes specially curated to evoke the trust and mutual respect that has grown out of our relationships...

read more

IMPACT’S Making an IMPACT Initiative Celebrates 2020

RESEARCH TRIANGLE PARK, NC: 10 February 2021 – In 2020, IMPACT’s (now Syner-G BioPharma Group’s) employees continued their generous efforts via the Making an IMPACT (MAI) community service initiative. The past year provided us opportunities to connect with various...

read more


100 Pennsylvania Avenue, Suite 310
Framingham, MA 01701

Contact Us


Follow Us